Literature DB >> 22201958

Oxidative stress and inflammatory bowel disease.

Hazem A Almenier1, Hazem H Al Menshawy, Maha M Maher, Salah Al Gamal.   

Abstract

Inflammatory Bowel Disease (IBD) is a chronic relapsing and remitting inflammatory condition of the gastrointestinal tract. The exact cause of IBD remains undetermined, the condition appears to be related to a combination of genetic and environmental factors. While many gaps in our knowledge still exist, the last two decades have witnessed an unprecedented progress not only in the etiology ; but mainly in the mechanisms underlying the chronic inflammatory response, immunologic and genetic aspects. We review some recent points of research in pathogenesis with special stress on oxidative stress and its correlations with disease activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22201958     DOI: 10.2741/463

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  19 in total

1.  Antioxidant and antiapoptotic properties of melatonin restore intestinal calcium absorption altered by menadione.

Authors:  A Carpentieri; A Marchionatti; V Areco; A Perez; V Centeno; N Tolosa de Talamoni
Journal:  Mol Cell Biochem       Date:  2013-11-15       Impact factor: 3.396

2.  The relationship between neutrophil/lymphocyte and platelet/lymphocyte ratios with oxidative stress in active Crohn's disease patients.

Authors:  F C Eraldemir; M Musul; A E Duman; B Oztas; C Baydemir; S Hulagu
Journal:  Hippokratia       Date:  2016 Oct-Dec       Impact factor: 0.471

Review 3.  Colon-specific prodrugs of 4-aminosalicylic acid for inflammatory bowel disease.

Authors:  Suneela S Dhaneshwar
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

Review 4.  Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease.

Authors:  Stewart Siyan Cao; Randal J Kaufman
Journal:  Antioxid Redox Signal       Date:  2014-06-12       Impact factor: 8.401

5.  Genomic and clinical effects associated with a relaxation response mind-body intervention in patients with irritable bowel syndrome and inflammatory bowel disease.

Authors:  Braden Kuo; Manoj Bhasin; Jolene Jacquart; Matthew A Scult; Lauren Slipp; Eric Isaac Kagan Riklin; Veronique Lepoutre; Nicole Comosa; Beth-Ann Norton; Allison Dassatti; Jessica Rosenblum; Andrea H Thurler; Brian C Surjanhata; Nicole N Hasheminejad; Leslee Kagan; Ellen Slawsby; Sowmya R Rao; Eric A Macklin; Gregory L Fricchione; Herbert Benson; Towia A Libermann; Joshua Korzenik; John W Denninger
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

6.  Chemoprevention of dietary digitoflavone on colitis-associated colon tumorigenesis through inducing Nrf2 signaling pathway and inhibition of inflammation.

Authors:  Yang Yang; Xueting Cai; Jie Yang; Xiaoyan Sun; Chunping Hu; Zhanpeng Yan; Xiaojun Xu; Wuguang Lu; Xiaoning Wang; Peng Cao
Journal:  Mol Cancer       Date:  2014-03-06       Impact factor: 27.401

7.  Bursopentin (BP5) protects dendritic cells from lipopolysaccharide-induced oxidative stress for immunosuppression.

Authors:  Tao Qin; Yinyan Yin; Qinghua Yu; Qian Yang
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

8.  The tumor suppressor gene, RASSF1A, is essential for protection against inflammation -induced injury.

Authors:  Marilyn Gordon; Mohamed El-Kalla; Yuewen Zhao; Yahya Fiteih; Jennifer Law; Natalia Volodko; Anwar Anwar-Mohamed; Anwar Mohamed; Ayman O S El-Kadi; Lei Liu; Jeff Odenbach; Aducio Thiesen; Christina Onyskiw; Haya Abu Ghazaleh; Jikyoung Park; Sean Bong Lee; Victor C Yu; Carlos Fernandez-Patron; R Todd Alexander; Eytan Wine; Shairaz Baksh
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

9.  Advanced oxidation protein products induce intestine epithelial cell death through a redox-dependent, c-jun N-terminal kinase and poly (ADP-ribose) polymerase-1-mediated pathway.

Authors:  F Xie; S Sun; A Xu; S Zheng; M Xue; P Wu; J H Zeng; L Bai
Journal:  Cell Death Dis       Date:  2014-01-16       Impact factor: 8.469

10.  An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis.

Authors:  Meng-Chen Lu; Jian-Ai Ji; Yong-Lin Jiang; Zhi-Yun Chen; Zhen-Wei Yuan; Qi-Dong You; Zheng-Yu Jiang
Journal:  Sci Rep       Date:  2016-05-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.